Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Uncovering The Science of Covid-19 ; : 63-95, 2022.
Article in English | Scopus | ID: covidwho-2274974

ABSTRACT

Much has been learnt about severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) since the beginning of theCoronavirus disease 2019 (COVID-19) pandemic, including its clinical manifestations, diagnosis, and management. Unlike its zoonotic predecessor SARS-CoV which was largely a symptomatic disease where fever was a hallmark, a significant proportion of SARS-CoV-2 infections can be asymptomatic (40%), while severe disease (requiring oxygen supplementation or ventilatory support) occurs in approximately 20%, and mortality in about 2% of infected patients. Extra-pulmonary COVID-19 manifestations are also more protean, compared to SARS. Supportive care is the mainstay of treatment for most patients, but for those who progress to severe COVID-19, antivirals such as remdesivir and immunomodulatory treatment (such as corticosteroids or theJAK-inhibitor, baricitinib) may improve outcomes. While further advances in the management of COVID-19 are anticipated (including novel therapies), prevention of infection through public health measures (including vaccination), will remain as vital facets in confronting this pandemic. © 2023 by World Scientific Publishing Co. Pte. Ltd.

2.
COVID-19 Pandemic Singapore ; : 127-150, 2022.
Article in English | Scopus | ID: covidwho-2194006
3.
Migrant Workers In Singapore: Lives And Labour In A Transient Migration Regime ; : 213-216, 2022.
Article in English | Scopus | ID: covidwho-2044876
4.
Annals of the Academy of Medicine, Singapore ; 50(11):856-858, 2021.
Article in English | MEDLINE | ID: covidwho-1558178
5.
Annals of the Academy of Medicine, Singapore ; 50(2):191-194, 2021.
Article in English | MEDLINE | ID: covidwho-1139114
6.
Annals Academy of Medicine Singapore ; 49(10):764-778, 2020.
Article in English | Web of Science | ID: covidwho-955159

ABSTRACT

As of 27 October 2020, there have been 57,980 confirmed cases of COVID-19 in Singapore, with 28 fatalities. To summarise the Singapore experience in managing and containing COVID-19 based on available published data and from relevant sources, a review of literature using research databases such as PubMed and OVID Medline, along with non-peer-reviewed articles and other sources, was conducted with the search terms 'COVID-19' and 'Singapore'. Research conducted in Singapore has provided insight into the clinical manifestations and period of infectivity of COVID-19, demonstrated evidence of pre-symptomatic transmission, linked infection clusters using serological tools, and highlighted aspects of hospital-based environmental contamination. It has also provided guidance for diagnostic testing and has described immune and virologic correlates with disease severity. Evidence of effectiveness of containment measures such as early border control, rigorous contact training, and calibrated social distancing measures have also been demonstrated. Singapore's multipronged strategy has been largely successful at containing COVID-19 and minimising fatalities, but the risk of re-emergence is high.

SELECTION OF CITATIONS
SEARCH DETAIL